Detalles de la búsqueda
1.
Estimating protection afforded by prior infection in preventing reinfection: Applying the test-negative study design.
Am J Epidemiol;
2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38061757
2.
Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant.
Clin Infect Dis;
75(1): e1188-e1191, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34657152
3.
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.
Clin Infect Dis;
73(7): e1830-e1840, 2021 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33315061
4.
Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar.
Emerg Infect Dis;
27(5): 1343-1352, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33900174
5.
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
PLoS Med;
18(12): e1003879, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34914711
6.
Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
JAMA;
326(19): 1930-1939, 2021 11 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34724027
7.
Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation.
Front Med (Lausanne);
11: 1363045, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38529118
8.
Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient.
Vaccine;
42(14): 3307-3320, 2024 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38616439
9.
Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar.
J Infect Public Health;
16(2): 250-256, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36603377
10.
Immediate and contributory causes of death in patients hospitalized with COVID-19.
Int J Infect Dis;
132: 4-8, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37061212
11.
Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study.
Lancet Infect Dis;
23(7): 816-827, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36913963
12.
Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study.
EBioMedicine;
95: 104734, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37515986
13.
Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study.
Int J Infect Dis;
136: 81-90, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37717648
14.
Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study.
EClinicalMedicine;
62: 102102, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37533414
15.
SARS-CoV-2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: A national cohort study.
Influenza Other Respir Viruses;
17(11): e13224, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38019700
16.
History of primary-series and booster vaccination and protection against Omicron reinfection.
Sci Adv;
9(40): eadh0761, 2023 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37792951
17.
COVID-19 risk score as a public health tool to guide targeted testing: A demonstration study in Qatar.
PLoS One;
17(7): e0271324, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35853026
18.
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage.
Nat Commun;
13(1): 4675, 2022 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35945213
19.
Duration of immune protection of SARS-CoV-2 natural infection against reinfection.
J Travel Med;
29(8)2022 12 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36179099
20.
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study.
Lancet Microbe;
3(12): e944-e955, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36375482